» Articles » PMID: 19932451

Combined Benzoporphyrin Derivative Monoacid Ring Photodynamic Therapy and Pulsed Dye Laser for Port Wine Stain Birthmarks

Overview
Publisher Elsevier
Date 2009 Nov 26
PMID 19932451
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulsed dye laser (PDL) is a commonly utilized treatment for port wine stain birthmarks (PWS) in the United States; however, results are variable and few patients achieve complete removal. Photodynamic therapy (PDT) is commonly used in China, but treatment associated photosensitivity lasts several weeks and scarring may occur. We propose an alternative treatment option, combined PDT+PDL and performed a proof-of-concept preliminary clinical trial.

Methods: Subjects with non-facial PWS were studied. Each subject had four test sites: control, PDL alone, PDT alone (benzoporphyrin derivative monoacid ring A photosensitizer with 576 nm light), and PDT+PDL. Radiant exposure time for PDT was increased in increments of 15 J/cm(2). Authors evaluated photographs and chromametric measurements before and 12 weeks post-treatment.

Results: No serious adverse events were reported; epidermal changes were mild and self-limited. No clinical blanching was noted in control or PDT-alone sites. At PDT radiant exposures of 15 and 30 J/cm(2), equivalent purpura and blanching was observed at PDL and PDT+PDL sites. At PDT radiant exposures over 30 J/cm(2), greater purpura was noted at PDT+PDL sites as compared to PDL alone. Starting at 75 J/cm(2), improved blanching was noted at PDT+PDL sites.

Conclusions: Preliminary results indicate that PDT+PDL is safe and may offer improved PWS treatment efficacy. Additional studies are warranted.

Citing Articles

The application of photodynamic therapy in plastic and reconstructive surgery.

Wu M, Huang X, Gao L, Zhou G, Xie F Front Chem. 2022; 10:967312.

PMID: 35936104 PMC: 9353173. DOI: 10.3389/fchem.2022.967312.


Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium.

Suzuki T, Tanaka M, Sasaki M, Ichikawa H, Nishie H, Kataoka H Cancers (Basel). 2020; 12(9).

PMID: 32825648 PMC: 7563359. DOI: 10.3390/cancers12092369.


Clinical outcome measures and scoring systems used in prospective studies of port wine stains: A systematic review.

van Raath M, Chohan S, Wolkerstorfer A, van der Horst C, Limpens J, Huang X PLoS One. 2020; 15(7):e0235657.

PMID: 32614899 PMC: 7332045. DOI: 10.1371/journal.pone.0235657.


Therapeutic Enhancement of Verteporfin-mediated Photodynamic Therapy by mTOR Inhibitors.

Kraus D, Palasuberniam P, Chen B Photochem Photobiol. 2019; 96(2):358-364.

PMID: 31769520 PMC: 7138740. DOI: 10.1111/php.13187.


Hemoporfin-mediated photodynamic therapy on normal vasculature: implications for phototherapy of port-wine stain birthmarks.

Moy W, Ma G, Kelly K, Choi B J Clin Transl Res. 2017; 2(3):107-111.

PMID: 29226252 PMC: 5722630. DOI: 10.18053/jctres.02.201603.003.


References
1.
Kelly K, Kimel S, Smith T, Stacy A, Hammer-Wilson M, Svaasand L . Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Lasers Surg Med. 2004; 34(5):407-13. DOI: 10.1002/lsm.20041. View

2.
Huang Y, Ringold T, Nelson J, Choi B . Noninvasive blood flow imaging for real-time feedback during laser therapy of port wine stain birthmarks. Lasers Surg Med. 2008; 40(3):167-73. PMC: 2680475. DOI: 10.1002/lsm.20619. View

3.
Gu Y, Huang N, Liang J, Pan Y, Liu F . [Clinical study of 1949 cases of port wine stains treated with vascular photodynamic therapy (Gu's PDT)]. Ann Dermatol Venereol. 2007; 134(3 Pt 1):241-4. DOI: 10.1016/s0151-9638(07)91816-5. View

4.
Huikeshoven M, Koster P, de Borgie C, Beek J, van Gemert M, van der Horst C . Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med. 2007; 356(12):1235-40. DOI: 10.1056/NEJMoa064329. View

5.
Lanigan S . Port-wine stains unresponsive to pulsed dye laser: explanations and solutions. Br J Dermatol. 1998; 139(2):173-7. DOI: 10.1046/j.1365-2133.1998.02351.x. View